INSINUATIONS OF MULTIFACTORIAL AUTOIMMUNE DISORDERS AND THEIR INTERPLAY TO DEVELOP RHEUMATOID ARTHRITIS: FROM INFLAMMATION TO BONE DEFORMITY
Main Article Content
Keywords
Rheumatoid arthritis, Autoimmune disorder, Malondialdehyde, Superoxide dismutase, Matrix Metalloproteinases, Interleukins
Abstract
Background: Rheumatoid arthritis (RA) is a chronic and autoimmune disorder which leads to the disability, deformity of joints and even death. The particular reason of the disease is still unknown; but it has been confirmed that it is a multifactorial disease influenced by environmental and genetic factors. Destruction of the joint is associated with the immunological abnormalities and inflammatory mechanisms.
Objectives: The aim of this study is to determine the role of anti-oxidants, inflammatory cytokines and MMPs in the progression and aggregation of RA.
Methods: Blood samples of hundred male patients with rheumatoid arthritis were collected from University teaching hospital, The University of Lahore. Hundred age and sex matched blood samples from healthy volunteers were also collected as a control. Levels of MDA, NO, GSH, SOD and CAT were estimated spectrophotometrically while interleukins, TNF-α, MMP2,MMP3 and MMP9 were estimated by using a commercially available ELISA kit.
Results: The MDA levels in RA patients were elevated significantly as compared to control subjects (2.59±0.017 Vs 1.29±0.006 nmol/ml). The serum NO levels in these patients were recorded (18.58±4.160 μmol/L) as compared to normal subjects (9.28±1.22 μmol/L). However, the serum SOD, CAT, GSH and Vit E levels were measured in RA patients with the significant decrease values of 0.056±0.001 U/L, 0.99±0.015 U/L, 2.99±0.951 μmol/L and 1.95±0.019 μg/ml respectively. On the other hand, the levels of IL-1 (6.19±1.49 pg/ml), IL-6 (6.19±1.49 pg/ml), IL-15 (4.29±1.08 pg/ml) and TNF-α (31.25±1.99 pg/ml) were significantly increased in the patients with RA. Meanwhile, the increased serum MMP-2, MMP-9 and MMP-3 in these RA patients were recorded (96.58±6.59 ng/ml), (109.65±8.26 ng/ml) and (133.29±7.88 ng/ml) respectively against their control values 31.26±5.66 ng/ml, 36.29±4.16 ng/ml and 41.26±6.58 ng/ml. The levels of neutrophils were also increased in RA patients versus control (89.26±5.0 vs 51.66±3.66 μ/L). These values evidently points out the significant increase in oxidative stress and inflammation in bones, joints and cartilage that consequently leads to progression of RA.
Conclusions: Several lines of evidence suggest that decline in anti-oxidants activity triggers to enhance oxidative insult in RA patients. The macrophages in RA release wide range of inflammatory cytokines such as interleukins and tumor necrosis factor alpha. This enhances the expression of inflammatory mediators potentiating damage of bones and cartilage by stimulating various proteolytic enzymes including MMPs. These MMPs triggers the degradation of bone, cartilage by degrading several extracellular components such as proteoglycans, collagen matrix protein and also regulating other MMPs in the patients with RA.
References
2. Das G, S Sheridan, Janeway CA. The source of early IFN-gamma that plays a role in Th1 priming. J Immunol 2001;167:2004-2010.
3. Christodoulou C, Choy EH. Joint inflammation and cytokine inhibition in rheumatoid arthritis.ClinExp Med 200;6:13-9.
4. Buch M, Emery P. The aetiology and pathogenesis of Rheumatoid Arthritis.Hosp Pharmacist 2002;9:5-10.
5. Granet C, W Maslinski, Miossec P. Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes. Arthritis Res Ther 2004;6:R190-R198.
6. Hadjigogos H. The role of free radicals in the pathogenesis of rheumatoid arthritis.PanminervaMedica 2003;45:7-13.
7. [7] Hassan MQ, RAHadi, ZSAl-Rawi, Padron VA, Stohs SJ. The glutathione defence system in the pathogenesis of rheumatoid arthritis. Journal of Applied Toxicology 2001;211:69-73.
8. Cawston TE, Wilson AJ. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Pract Res ClinRheumatol 2006;20(5):983-1002.
9. Ma JD, JJ Zhou,Zheng DH, Chen LH, Mo YQ, Wei XN. Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis. Mediators Inflamm 2014;179284.
10. Echtermeyer F, Bertrand J, Dreier R,Meinecke I,Neugebauer K, Fuerst M. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med 2009;15:1072-6.
11. Goldring SR. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.Rheumatology2009;422:11-6.
12. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;1:1504-8.
13. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry 1979;95(2):351-8. PMID: 36810.
14. Kakkar P, Das B, Viswanathan PA. A modified spectrophotometric assay of superoxide dismutase.Indian J BiochemBiophys1984;21(2):130-2. PMID: 6490072
15. [15] Moron MS, JW Depierre, Mannervik B. Levels of glutathione, glutathione reductase and glutathione Stransferase activities in rat lung and liver. Biochimica et BiophysicaActa (BBA)-General Subjects 1979;582(1):67-78.
16. Abei H. Catalase in methods of enzymatic analysis. Bergmeyer HU, VerlagChemie. Academic Press,NY 1974.
17. Ozturk HS, Cimen MYB,Cimen OB,Kacmaz M,Drek J. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. RheumatolInt 1999;19:35-37.
18. Rasool M, Malik A, Basit Ashraf MA,Parveen G,Iqbal S, Ali I et al. Evaluation of matrix metalloproteinases, cytokines and their potential role in the development of ovarian cancer. PLoS ONE 2016;11(1): e0167149. doi:10.1371/ journal.pone.0167149
19. Ali AM, Habeeb RA, El-Azizi NO,Khattab DA, Abo-Shady RA, Elkabarity RH. Higher nitric oxide levels are associated with disease activity in Egyptian rheumatoid arthritis patients. Rev Bras Reumatol 2014;54:211-266.
20. Recklies AD, Poole AR, Banerjee S, Bogoch E,Dibattista J, Evans CH. Pathophysiologic aspects of inflammation in diarthroidal joints. In: Buckwalter JA, Einhorn TA, Simon SR, editors. Orthopaedic basic science: biology and biomechanics of the musculoskeletal system, 2nd ed. Rosemont, IL: AAOS 2000;489-530.
21. Akyol O,Iscedilc IN, Temel I,Ozgo S,Uz E, Murat M. The relationships between plasma and erythrocyte antioxidant enzymes and lipid peroxidation in patients with rheumatoid arthritis. Joint Bone Spine 2001;68:311-7.
22. Surapaneni KM, Venkataramana G. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with osteoarthritis. Indian J Med Sci 2007;61(1):9-14.
23. El-Sohemy A, Cornelis MC, Park YW, Bae SC. Catalase and PPARgamma2 genotype and risk of rheumatoid arthritis in Koreans. RheumatolInt 2006;26:388-92.
24. Yaron I, Meyer FA,Dayer JM, Bleiberg I, Yaron M. Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit it in human articular cartilage cultures. Arthritis Rheum 1989;32:173-80.
25. Dinarello CA. Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw. 2000;11:483-6.
26. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, Kishimoto T, Suda T. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc. Natl Acad. Sci 1993;90:11924-11928.
27. Hashizume M, ayakawaand NH, Mihara M. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology 2008;47:1635-1640.
28. Van den Berg WB. Uncoupling of inflammatory and destructive mechanisms in arthritis.Semin Arthritis Rheum 2001;(2):7-16.
29. Shaulian E and M Karin. AP-1 as a regulator of cell life and death.Nat Cell Biol 2002; 4:131-136.
30. Rodriguez-Carreon AA, Zuniga J, Hernandez-Pacheco G. Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. J Autoimmun 2005;24:63-68.
31. Jovanovic DV, Martel-Pelletier J, Di Battista JA, Mineau, Jolicoeur FC, JP Benderdour. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis Rheum 2000;43:1134.